Literature DB >> 11472605

Incidence, impact on survival, and risk factors for multi-organ system failure in children following liver transplantation.

H J Feickert1, A K Schepers, B Rodeck, H Geerlings, P F Hoyer.   

Abstract

Liver transplantation (LTx) in children currently offers long-term survival rates of more than 80%. Many causes for Tx failure have been identified. However, the incidence and impact of multi-organ system failure (MOSF) are, to date, unknown. Therefore, in this study the role of MOSF after LTx in children was investigated with regard to outcome. The data of 114 children (53 girls, 61 boys; median age 4.3 yr) after first LTx were evaluated retrospectively. The definition of MOSF, as used by Wilkinson et al. [Crit Care Med 1986: 14: 271-274], was modified with regard to age-adjusted values. The influence of MOSF on patient survival was investigated by Kaplan-Meier analysis and multivariate regression analysis. Thirty-one of 114 children with orthotopic LTx developed MOSF (involving two or more organs). In total, 18 children died (15.8%) during the hospitalization; 16 of these had MOSF. Mortality related to two-organ failure was 29.4% (n = 5), to three-organ failure 78% (n = 7), and to four-organ failure 80% (n = 4). The highest mortality rates were observed in children with central nervous system (CNS) and cardiovascular failure, leading to a decreased probability of survival of 0.40 (p < 0.0001). Multi-variate analysis showed that CNS and cardiovascular failure were the most important risk factors for survival (p < 0.0001 and 0.056, respectively). Respiratory and renal failure, in univariate analysis, were significant contributors to poor survival, but had no statistically significant influence on outcome in multivariate analysis. Bone marrow insufficiency was found to have no influence on survival in either analysis. In multivariate analysis, the risk of development of MOSF was significantly increased by high numbers of transfused units of fresh-frozen plasma (FFP), the absence of rejection episodes, or a high bilirubin level prior to Tx. Hence, MOSF is a major factor contributing to the death of children early after LTx. CNS and cardiovascular failure carried the highest risk for a poor outcome. Other risk factors associated with the development of MOSF were: numbers of transfused units of FFP, absence of rejection episodes, and a high pre-Tx bilirubin level.

Entities:  

Mesh:

Year:  2001        PMID: 11472605     DOI: 10.1034/j.1399-3046.2001.005004266.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

Review 1.  Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  R Scott Watson; Sheri S Crow; Mary E Hartman; Jacques Lacroix; Folafoluwa O Odetola
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

2.  Outcomes Associated With Multiple Organ Dysfunction Syndrome in Critically Ill Children With Hyperglycemia.

Authors:  Lauren E Marsillio; Lisa A Asaro; Vijay Srinivasan; David Wypij; Lauren R Sorce; Michael S D Agus; Vinay M Nadkarni
Journal:  Pediatr Crit Care Med       Date:  2019-12       Impact factor: 3.624

3.  A pediatric massive transfusion protocol.

Authors:  Sara J Chidester; Nick Williams; Wei Wang; Jonathan I Groner
Journal:  J Trauma Acute Care Surg       Date:  2012-11       Impact factor: 3.313

Review 4.  Adverse effects of plasma transfusion.

Authors:  Suchitra Pandey; Girish N Vyas
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

5.  Interleukin-6 as inflammatory marker referring to multiple organ dysfunction syndrome in severely injured children.

Authors:  Hagen Andruszkow; Janika Fischer; Michael Sasse; Ulf Brunnemer; Julia Helga Karla Andruszkow; Axel Gänsslen; Frank Hildebrand; Michael Frink
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-03-03       Impact factor: 2.953

6.  Management of preterm giant sacrococcygeal teratoma (GSCT) with an excellent outcome.

Authors:  Meera Gangadharan; Sanjeet Panda; P Stephen Almond; Vaidehi Agrawal; Angelina Bhandari; A Jay Koska
Journal:  J Surg Case Rep       Date:  2014-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.